BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26350190)

  • 1. Early changes of volume and spatial location in target and normal tissues caused by IMRT for cervical cancer.
    Chen J; Liu P; Chen W; Bai P; Li J; Ni X; Chen K; Li Q
    Tumori; 2016 Dec; 102(6):610-613. PubMed ID: 26350190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Tumor Volumes and Spatial Locations Relative to Normal Tissues During Cervical Cancer Radiotherapy Assessed by Cone Beam Computed Tomography.
    Chen W; Bai P; Pan J; Xu Y; Chen K
    Technol Cancer Res Treat; 2017 Apr; 16(2):246-252. PubMed ID: 28052737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
    Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
    Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma.
    D'Souza WD; Ahamad AA; Iyer RB; Salehpour MR; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1062-70. PubMed ID: 15752885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
    van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
    Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
    Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric study of volumetric arc modulation with RapidArc and intensity-modulated radiotherapy in patients with cervical cancer and comparison with 3-dimensional conformal technique for definitive radiotherapy in patients with cervical cancer.
    Guy JB; Falk AT; Auberdiac P; Cartier L; Vallard A; Ollier E; Trone JC; Khodri M; Chargari C; Magné N
    Med Dosim; 2016; 41(1):9-14. PubMed ID: 26212351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.
    Cozzi L; Dinshaw KA; Shrivastava SK; Mahantshetty U; Engineer R; Deshpande DD; Jamema SV; Vanetti E; Clivio A; Nicolini G; Fogliata A
    Radiother Oncol; 2008 Nov; 89(2):180-91. PubMed ID: 18692929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
    Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
    Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
    Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dosimetric comparison between the intensity modulated radiotherapy with fixed field and Rapid Arc of cervix cancer].
    Renard-Oldrini S; Brunaud C; Huger S; Marchesi V; Tournier-Rangeard L; Bouzid D; Harter V; Peiffert D
    Cancer Radiother; 2012 May; 16(3):209-14. PubMed ID: 22498094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.
    Duffton A; Harrow S; Lamb C; McJury M
    Br J Radiol; 2016 Jun; 89(1062):20150492. PubMed ID: 27052681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cerebral malignant gliomas.
    Zheng R; Fan R; Wen H; Luo J; Yang Y
    J BUON; 2015; 20(1):248-52. PubMed ID: 25778324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
    Lee NY; Mechalakos JG; Nehmeh S; Lin Z; Squire OD; Cai S; Chan K; Zanzonico PB; Greco C; Ling CC; Humm JL; Schöder H
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):2-13. PubMed ID: 17869020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.